Vis enkel innførsel

dc.contributor.authorFauske, Lena
dc.contributor.authorBruland, Oyvind S.
dc.contributor.authorGrov, Ellen Karine
dc.contributor.authorBondevik, Hilde
dc.date.accessioned2016-04-21T07:28:19Z
dc.date.available2016-04-21T07:28:19Z
dc.date.issued2015
dc.identifier.citationFauske, L., Bruland, O. S., Grov, E. K., & Bondevik, H. (2015). Cured of primary bone cancer, but at what cost: a qualitative study of functional impairment and lost opportunities. Sarcoma, 2015.en_US
dc.identifier.issn1357-714X
dc.identifier.otherFRIDAID 1241841
dc.identifier.urihttps://hdl.handle.net/10642/3257
dc.description.abstractPurpose. Our study aims to explore how former cancer patients experience physical and psychosocial late effects 3–7 years after they underwent treatment for primary bone sarcoma in the hip/pelvic region. A qualitative, phenomenological, and hermeneutic design was applied. Methods. Sarcoma survivors () previously treated at Oslo University Hospital, Norwegian Radium Hospital were selected to participate. In-depth and semistructured interviews were conducted. The interviews were analysed using inductive thematic analysis. Results. The participants reported that the late effects had three core spheres of impact: “their current daily life,” “their future opportunities,” and “their identity.” They expressed negative changes in activity, increased dependence on others, and exclusion from participation in different areas. Their daily life, work, sports activities, and social life were all affected. Several of their experiences are similar to those described by people with functional impairment or disability. Conclusion. Patients cured of bone cancer in the hip/pelvic region pay a significant price in terms of functional impairment, practical challenges, exclusion from important aspects of life, and loss of previous identity. It is important to appreciate this in order to help bone cancer survivors who struggle to reorient their life and build a secure new identity.en_US
dc.language.isoengen_US
dc.publisherHindawi Publishing Corporationen_US
dc.relation.ispartofseriesSarcoma;2015
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Sykepleievitenskap: 808en_US
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762en_US
dc.titleCured of Primary Bone Cancer, But at What Cost: A Qualitative Study of Functional Impairment and Lost Opportunitiesen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionCopyright © 2015 Lena Fauske et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
dc.identifier.doihttp://dx.doi.org/10.1155/2015/484196


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel